BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 27955974)

  • 1. Increased access to transplantation of highly sensitized patients under the new kidney allocation system. A single center experience.
    Colovai AI; Ajaimy M; Kamal LG; Masiakos P; Chan S; Savchik C; Lubetzky M; de Boccardo G; Courson A; Chokechanachaisakul A; Graham J; Greenstein S; Kinkhabwala M; Rocca J; Akalin E
    Hum Immunol; 2017 Mar; 78(3):257-262. PubMed ID: 27955974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The national landscape of deceased donor kidney transplantation for the highly sensitized: Transplant rates, waitlist mortality, and posttransplant survival under KAS.
    Jackson KR; Covarrubias K; Holscher CM; Luo X; Chen J; Massie AB; Desai N; Brennan DC; Segev DL; Garonzik-Wang J
    Am J Transplant; 2019 Apr; 19(4):1129-1138. PubMed ID: 30372592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Introduction of cPRA and Its Impact on Access to Deceased Donor Kidney Transplantation for Highly Sensitized Patients in Australia.
    Sypek MP; Kausman JY; Watson N; Wyburn K; Holt SG; Hughes P; Clayton PA
    Transplantation; 2021 Jun; 105(6):1317-1325. PubMed ID: 34019363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-risk delisting strategy in highly sensitized patients without donor offers included in exchange donation programs. One single-center experience.
    Comins-Boo A; Irure-Ventura J; Valentin MO; Belmar-Vega L; López Del Moral Cuesta C; Valero San Cecilio R; Rodrigo Calabia E; Renuncio-García M; Castro Hernández C; Mikhalkovich D; Mota Pérez N; Ruiz San Millán JC; López-Hoyos M; San Segundo D
    Hum Immunol; 2024 May; 85(3):110806. PubMed ID: 38664156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kidney allocation system does not appropriately stratify risk of pediatric donor kidneys: Implications for pediatric recipients.
    Nazarian SM; Peng AW; Duggirala B; Gupta M; Bittermann T; Amaral S; Levine MH
    Am J Transplant; 2018 Mar; 18(3):574-579. PubMed ID: 28805300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major Variation across Local Transplant Centers in Probability of Kidney Transplant for Wait-Listed Patients.
    King KL; Husain SA; Schold JD; Patzer RE; Reese PP; Jin Z; Ratner LE; Cohen DJ; Pastan SO; Mohan S
    J Am Soc Nephrol; 2020 Dec; 31(12):2900-2911. PubMed ID: 33037131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial/ethnic disparities in waitlisting for deceased donor kidney transplantation 1 year after implementation of the new national kidney allocation system.
    Zhang X; Melanson TA; Plantinga LC; Basu M; Pastan SO; Mohan S; Howard DH; Hockenberry JM; Garber MD; Patzer RE
    Am J Transplant; 2018 Aug; 18(8):1936-1946. PubMed ID: 29603644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in offer and acceptance patterns for pediatric kidney transplant candidates under the new Kidney Allocation System.
    Jackson KR; Bowring MG; Kernodle A; Boyarsky B; Desai N; Charnaya O; Garonzik-Wang J; Massie AB; Segev DL
    Am J Transplant; 2020 Aug; 20(8):2234-2242. PubMed ID: 32012451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do highly sensitized patients get kidney transplants in the United States? Trends over the last decade.
    Jackson KR; Motter JD; Kernodle A; Desai N; Thomas AG; Massie AB; Garonzik-Wang JM; Segev DL
    Am J Transplant; 2020 Aug; 20(8):2101-2112. PubMed ID: 32065704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition probabilities between changing sensitization levels, waitlist activity status and competing-risk kidney transplant outcomes using multi-state modeling.
    Kulkarni S; Hall I; Formica R; Thiessen C; Stewart D; Gan G; Greene E; Deng Y
    PLoS One; 2017; 12(12):e0190277. PubMed ID: 29287087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does bortezomib influence pre-transplant desensitization therapy or benefit post-heart transplant outcomes for highly sensitized patients?
    Dhillon M; Kobashigawa JA; Kittleson M; Jain R; Patel N; Singer-Englar T; Zhang X; Hakimi M; Aintablian T; Vescio R; Dilibero D; Kransdorf E; Czer L; Nikolova AP; Patel JK
    Clin Transplant; 2024 Jan; 38(1):e15165. PubMed ID: 37837612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO-adjusted cPRA metric for kidney allocation in an Asian-predominant population.
    Lau KM; Chu PWK; Tang LWM; Chen BPY; Yeung NKM; Ip P; Lee P; Yap DYH; Kwok JSY
    HLA; 2024 Jan; 103(1):e15229. PubMed ID: 37728213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the Kidney Allocation Revision on Access to Kidney Transplantation and Outcomes in the United States.
    Akinyemi OA; Weldeslase TA; Odusanya EA; Hughes K; Cornwell EE; Callender CO
    Am Surg; 2024 Jul; 90(7):1886-1891. PubMed ID: 38531806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of excess mortality after implementation of the new kidney allocation system may be borne disproportionately by middle-aged recipients.
    Butler CR; Perkins JD; Johnson CK; Blosser CD; Bakthavatsalam R; Leca N; Sibulesky L
    PLoS One; 2019; 14(1):e0210589. PubMed ID: 30677058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unfinished journey toward transplant equity: an analysis of racial/ethnic disparities for children after the implementation of the Kidney Allocation System in 2014.
    Charnaya O; Zeiser L; Yisar D; Goldberg A; Segev DL; Massie A; Garonzik-Wang J; Verghese P
    Pediatr Nephrol; 2023 Apr; 38(4):1275-1289. PubMed ID: 35816202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the Access of Highly Sensitized Patients to Kidney Transplantation From Deceased Donors: The Spanish PATHI Program With Allocation Based on the Virtual Crossmatch.
    Valentin MO; Crespo M; Fernandez C; Muro M; Vega R; Palou E; Ruiz JC; Diekman F; Padilla M; Mancebo E; Perez I; Andres A; Ontañon J; Dominguez-Gil B;
    Transplantation; 2024 Mar; 108(3):787-801. PubMed ID: 37867239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cPRA Increases With DQA, DPA, and DPB Unacceptable Antigens in the Canadian cPRA Calculator.
    Tinckam KJ; Liwski R; Pochinco D; Mousseau M; Grattan A; Nickerson P; Campbell P
    Am J Transplant; 2015 Dec; 15(12):3194-201. PubMed ID: 26080906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant.
    Vincenti F; Bestard O; Brar A; Cruzado JM; Seron D; Gaber AO; Ali N; Tambur AR; Lee H; Abbadessa G; Paul JA; Dudek M; Siegel RJ; Torija A; Semiond D; Lépine L; Ternes N; Montgomery RA; Stegall M
    J Am Soc Nephrol; 2024 Mar; 35(3):347-360. PubMed ID: 38147137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunized Patients Face Reduced Access to Transplantation in the Eurotransplant Kidney Allocation System.
    de Ferrante H; Smeulders B; Tieken I; Heidt S; Haasnoot GW; Claas FHJ; Vogelaar S; Spieksma F
    Transplantation; 2023 Oct; 107(10):2247-2254. PubMed ID: 37291726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waiting time for kidney transplantation based on calculated panel reactive antibodies: experience of a southern Brazilian center.
    Ramos LA; Schiavo T; Montagner J; Bundcher C; Kist R; Garcia VD; Neumann J; Keitel E
    J Bras Nefrol; 2024; 46(1):79-84. PubMed ID: 37791791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.